Cargando…
ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The International AIDS Society
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113031/ http://dx.doi.org/10.1186/1758-2652-13-S4-P3 |
| _version_ | 1782205872349380608 |
|---|---|
| author | Orkin, C DeJesus, E Khanlou, H Stoehr, A Supparatpinyo, K Van de Casteele, T Lathouwers, E Spinosa-Guzman, S |
| author_facet | Orkin, C DeJesus, E Khanlou, H Stoehr, A Supparatpinyo, K Van de Casteele, T Lathouwers, E Spinosa-Guzman, S |
| author_sort | Orkin, C |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3113031 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | The International AIDS Society |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-31130312011-06-13 ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults Orkin, C DeJesus, E Khanlou, H Stoehr, A Supparatpinyo, K Van de Casteele, T Lathouwers, E Spinosa-Guzman, S J Int AIDS Soc Poster Presentation The International AIDS Society 2010-11-08 /pmc/articles/PMC3113031/ http://dx.doi.org/10.1186/1758-2652-13-S4-P3 Text en Copyright ©2010 Orkin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Orkin, C DeJesus, E Khanlou, H Stoehr, A Supparatpinyo, K Van de Casteele, T Lathouwers, E Spinosa-Guzman, S ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults |
| title | ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults |
| title_full | ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults |
| title_fullStr | ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults |
| title_full_unstemmed | ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults |
| title_short | ARTEMIS: 192-week efficacy and safety of once-daily darunavir/ritonavir (DRV/r) vs lopinavir/r (LPV/r) in treatment-naïve HIV-1-infected adults |
| title_sort | artemis: 192-week efficacy and safety of once-daily darunavir/ritonavir (drv/r) vs lopinavir/r (lpv/r) in treatment-naïve hiv-1-infected adults |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113031/ http://dx.doi.org/10.1186/1758-2652-13-S4-P3 |
| work_keys_str_mv | AT orkinc artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT dejesuse artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT khanlouh artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT stoehra artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT supparatpinyok artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT vandecasteelet artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT lathouwerse artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults AT spinosaguzmans artemis192weekefficacyandsafetyofoncedailydarunavirritonavirdrvrvslopinavirrlpvrintreatmentnaivehiv1infectedadults |